Stock Price & Analysis

Based on the provided data, here's a concise analysis of BNGO stock:

Technical Analysis

The stock is showing significant weakness, currently trading at $0.1934 with a regular market decline of -5.89% and further post-market drop of -1.60% . The stock is trading well below its 20-day moving average of $0.23, indicating a strong downward trend.

Recent Events

• January 3, 2025: BNGO completed a $10 million registered direct offering at $0.252 per share with warrants
• Q3 2024: Revenue guidance was cut to $6.5M-$6.8M from previous $7.9M-$8.9M, significantly below consensus of $7.85M
• Cash position: $23.3M as of September 30, 2024, with $11.4M subject to restrictions

Market Sentiment The RSI of 40.16 indicates the stock is approaching oversold territory but hasn't reached extreme levels yet. The negative MACD (-0.01) suggests continued bearish momentum.

Recommendation Based on the technical indicators, recent dilutive financing, and deteriorating fundamentals, selling BNGO appears to be the more prudent action at current levels.

Based on the provided data and recent developments, here's the price prediction analysis for BNGO stock in 2025:

BNGO's stock price is expected to remain under significant pressure at around $0.15-0.20 through 2025, primarily due to the recent dilutive financing announced on January 3, 2025, where the company sold 39.68 million shares at $0.25 per share to raise approximately $10 million. The continued cash burn and weak Q3 2024 revenue guidance of $6.5-6.8M (below consensus of $7.85M) suggests ongoing operational challenges that will likely keep weighing on the stock price.

The technical analysis shows BNGO is in a strong downtrend with RSI at 40.16 indicating bearish momentum. The stock has broken below key support levels and faces significant overhead resistance around $0.25-0.30 range.

The S1 support level for BNGO Stock is $0.13 ,The R1 resistant level for BNGO Stock is $0.24.

As of the end of day on 2025-01-24, the price of BNGO Stock was $7.296.

The target price for BNGO Stock according to analyst rating is 1.00, with the highest price target at 1.00 and the lowest at 1.00. Analysts have a Hold rating on BNGO Stock overall.

The market cap of BNGO is $17.0M.

Based on the provided data, BNGO appears significantly overvalued despite its low share price of $0.19. The company's recent Q3 2024 revenue guidance cut from $7.9M-$8.9M to $6.5M-$6.8M indicates deteriorating business fundamentals. Multiple analyst downgrades in late 2024, including from Ladenburg Thalmann and BTIG, reflect growing concerns about the company's restructuring uncertainty. The company's recent $10M stock offering at $0.25 per share in January 2025 suggests urgent capital needs and potential dilution risks. The stock's price-to-sales ratio remains elevated compared to industry peers, while the company continues to burn cash with no clear path to profitability.

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Based on the provided data and market context, here's a price prediction analysis for BNGO stock by 2030:

BNGO's stock price is projected to reach $0.85 by 2030, considering the company's current financial position and recent strategic developments. The prediction is based on three key factors: 1) The company's recent $10 million capital raise through a registered direct offering of 39.68 million shares at $0.252 per share in January 2025, indicating significant dilution but providing essential working capital. 2) The downward revision of Q3 2024 revenue guidance to $6.5-6.8M from $7.9-8.9M, suggesting near-term operational challenges. 3) The stock's persistent downward trend since 2024, with current trading around $0.19, reflecting market skepticism about the company's growth prospects.

BNGO has a total of 344 employees.